Marley Lites, PA
Medical · Dallas, TXNPI 1477028041
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 449 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 26.7% of the total. Reporting peaked in 2022 at $3,267 and has fallen 93.1% since, to $225 in 2025. Among medical clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 449 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Bristol Myers Squibb$685
- Johnson & Johnson$534
- Ferring Pharmaceuticals Inc.$476
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$472
- plus $3K from 18 others
What the payments were for
- Food & beverage$7,98598%
- Education$1552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 122 | $2,175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 58 | $1,116 |
| Bristol Myers Squibb | 64 | $685 |
| Johnson & Johnson | 32 | $534 |
| Ferring Pharmaceuticals Inc. | 17 | $476 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $472 |
| Redhill Biopharma Inc. | 31 | $395 |
| Nestle Healthcare Nutrition Inc. | 16 | $237 |
| Ironwood Pharmaceuticals, Inc | 11 | $229 |
| Fresenius Kabi USA, LLC | 4 | $226 |
| E.r. Squibb & Sons, L.L.C. | 2 | $205 |
| Pfizer | 14 | $193 |
| Merck | 9 | $187 |
| Regeneron Healthcare Solutions, Inc. | 7 | $164 |
| Intercept Pharmaceuticals, Inc. | 7 | $161 |
| QOL Medical, LLC | 8 | $144 |
| Therakos LLC | 1 | $126 |
| Braintree Laboratories, Inc. | 7 | $114 |
| Gamida Cell Inc. | 1 | $99 |
| Ardelyx, Inc. | 4 | $72 |
| Sanofi | 2 | $65 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPOSIA$135
- REBYOTA$128
- UVADEX$126
- CELLEX$126
- Amicus Separator$125
How this compares
$8,140 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 15 | $1,350 |
| Omeprazole | 40 | $593 |
| Pantoprazole Sodium | 45 | $483 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Shakira CabreraSan Antonio$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.